Inhaled Glucocoriticoids in Children: A Facourable Therapeutic Index. Issue 2 (3rd April 1999)

• Record Type: Journal Article
• Authors: Simons, F Estelle R
• Is Part Of: Canadian respiratory journal. Volume 6:Issue 2(1999)
• Page Start: 175
• Page End: 178
• Publication Date: 1999-04-03
• Subjects: Asthma -- Beclomethasone dipropionate -- Budesonide -- Children -- Fluticasone propionate -- Growth -- Inhaled glucocorticoids; Respiratory organs -- Diseases -- Periodicals; Respiration -- Canada -- Periodicals; Respiration; Respiratory organs -- Diseases; Canada; Respiratory Tract Diseases -- Periodicals; Periodicals; Periodicals; 616.2
• DOI: 10.1155/1999/957127
• Languages: English
• ISSNs: 1198-2241

Abstract

Abstract : In children with persistent asthma, inhaled glucocorticoids decrease symptoms and exacerbations, decrease the need for rescue bronchodilator medications, improve airway patency and reduce airway hyperresponsiveness. When administered in the lowest doses that prevent symptoms and eliminate the need for supplemental courses of oral glucocorticoids, they are unlikely to cause clinically important systemic adverse events. Inhaled glucocorticoids have a favourable risk to benefit ratio in this population.